The Vyleesi Resubmission Journey: From FDA CRL to Approval
Hello Regulatory Scientists, Today, let’s explore the journey of Vyleesi (bremelanotide) from receiving an FDA Complete Response Letter (CRL) to achieving approval. This case study provides valuable insights and lessons that can guide companies developing new drugs today. Regulatory History and Initial Submission Drug: Vyleesi (bremelanotide) Mechanism of Action: Melanocortin receptor agonist, which activates melanocortin receptors […]
Unleashing the Power of Cell Therapy
Introduction: In the realm of medical advancements, cell therapy stands as a beacon of hope, offering a revolutionary approach to healing that transcends traditional treatment methods. This groundbreaking field harnesses the body’s own cellular power to combat diseases and promote regeneration. Join us on a journey through the wonders of cell therapy and discover how […]